115 related articles for article (PubMed ID: 11504529)
1. Zang RY, Zhang ZY, Li ZT et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol 2000; 26:798-804.
Sugarbaker PH
Eur J Surg Oncol; 2001 Aug; 27(5):515-6. PubMed ID: 11504529
[No Abstract] [Full Text] [Related]
2. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience.
Ayhan A; Gultekin M; Taskiran C; Aksan G; Celik NY; Dursun P; Salman MC; Yuce K; Kucukali T
Am J Obstet Gynecol; 2006 Jan; 194(1):49-56. PubMed ID: 16389009
[TBL] [Abstract][Full Text] [Related]
3. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
4. Secondary cytoreduction in ovarian cancer: pro or con?
Potter ME
Gynecol Oncol; 1993 Oct; 51(1):131-5. PubMed ID: 8244168
[TBL] [Abstract][Full Text] [Related]
5. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
6. Secondary surgery for epithelial ovarian cancer.
Ball HG
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):57-63. PubMed ID: 2102307
[No Abstract] [Full Text] [Related]
7. Surgery of advanced malignant epithelial tumours of the ovary.
Favalli G; Odicino F; Pecorelli S
Forum (Genova); 2000; 10(4):312-20. PubMed ID: 11535982
[TBL] [Abstract][Full Text] [Related]
8. Debulking surgery for incompletely operated advanced epithelial ovarian carcinoma.
Gultekin M; Dursun P; Doğan NU; Kolusari A; Yuce K; Ayhan A
J Surg Oncol; 2009 Sep; 100(3):258-60. PubMed ID: 19347889
[TBL] [Abstract][Full Text] [Related]
9. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
Zivanovic O; Braun M; Park TW; Kuhn W
Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
[TBL] [Abstract][Full Text] [Related]
10. A third evaluation of tertiary cytoreduction.
Gultekin M; Velipaşaoğlu M; Aksan G; Dursun P; Dogan NU; Yuce K; Ayhan A
J Surg Oncol; 2008 Dec; 98(7):530-4. PubMed ID: 18937233
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
12. Recurrent micropapillary serous ovarian carcinoma.
Bristow RE; Gossett DR; Shook DR; Zahurak ML; Tomacruz RS; Armstrong DK; Montz FJ
Cancer; 2002 Aug; 95(4):791-800. PubMed ID: 12209723
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of secondary cytoreductive surgery for recurrent advanced ovarian cancer].
Zang R; Zhang Z; Cai S
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):194-6. PubMed ID: 12015048
[TBL] [Abstract][Full Text] [Related]
14. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
15. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Scarabelli C; Gallo A; Carbone A
Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
Helm CW; Bristow RE; Kusamura S; Baratti D; Deraco M
J Surg Oncol; 2008 Sep; 98(4):283-90. PubMed ID: 18726895
[TBL] [Abstract][Full Text] [Related]
17. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
18. The surgical management of women with ovarian cancer in the south west of England.
Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
[TBL] [Abstract][Full Text] [Related]
19. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
[TBL] [Abstract][Full Text] [Related]
20. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
